Torkildsen, G., Narvekar, A., & Bergmann, M. (2015). Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model. Clin Ophthalmol.
Style de citation ChicagoTorkildsen, Gail, Abhijit Narvekar, et Mark Bergmann. "Efficacy and Safety of Olopatadine Hydrochloride 0.77% in Patients With Allergic Conjunctivitis Using a Conjunctival Allergen-challenge Model." Clin Ophthalmol 2015.
Style de citation MLATorkildsen, Gail, Abhijit Narvekar, et Mark Bergmann. "Efficacy and Safety of Olopatadine Hydrochloride 0.77% in Patients With Allergic Conjunctivitis Using a Conjunctival Allergen-challenge Model." Clin Ophthalmol 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.